unknown
Stage
About
EVQLV develops a proprietary computational platform that accelerates the discovery and design of fully-human antibodies using machine learning and computational biology techniques.
Explore EVQLV's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.